PsyAtlas

Where psychedelic therapy is legal.

Legality here is not one question but three: is the substance a prescription medicine (ketamine, esketamine), is there a licensed program (Oregon, Colorado, Australia), or was it simply never banned (Jamaica, Dutch truffles)? Laws move; this guide was last reviewed in August 2026, and every section links to an official source where one exists. PsyAtlas only lists providers operating through one of these doors.

United States

Legal, prescribed off-label

Ketamine is an FDA-approved anesthetic that licensed clinicians can prescribe off-label for depression, PTSD, and chronic pain. Clinics operate in every state under standard medical licensing.

Who can apply: A psychiatric or medical evaluation at the clinic; most clinics accept self-referral. All requirements

389 listings under this basisOfficial source: FDA statement on compounded ketamine

United States

FDA-approved, certified centers

Esketamine (Spravato) is FDA-approved for treatment-resistant depression. It is administered only at certified treatment centers under a federal safety program, and is frequently covered by insurance.

Who can apply: A depression diagnosis that has not responded to at least two oral antidepressants, or major depression with acute suicidal thinking. All requirements

1441 listings under this basisOfficial source: Spravato REMS program

Oregon, United States

Licensed psilocybin program

Oregon voters passed Measure 109 in 2020. Since 2023, adults 21+ can book psilocybin sessions at state-licensed service centers with trained facilitators. No prescription or diagnosis is required, and sessions happen on site.

Who can apply: 21 or older with government ID; you do not need to be an Oregon resident. All requirements

19 listings under this basisOfficial source: Oregon Psilocybin Services (OHA)

Colorado, United States

Licensed healing centers

Colorado's Proposition 122 created the Natural Medicine program. State-licensed healing centers began offering supervised psilocybin sessions in 2025 under the Natural Medicine Division.

Who can apply: 21 or older; no diagnosis or prescription required. All requirements

45 listings under this basisOfficial source: Colorado Natural Medicine Division

Australia

Authorised prescribers

Since July 2023, psychiatrists approved by the TGA as authorised prescribers can prescribe psilocybin for treatment-resistant depression and MDMA for PTSD. Treatment runs through specialist clinics with extensive screening.

Who can apply: Assessment by a psychiatrist holding TGA Authorised Prescriber status for psilocybin or MDMA. All requirements

6 listings under this basisOfficial source: TGA guidance on psilocybin and MDMA

Australia

Legal, prescribed off-label

Australian clinics offer ketamine and esketamine for treatment-resistant depression under specialist prescription, in line with TGA and state regulations.

Who can apply: Most clinics require a GP or psychiatrist referral. All requirements

2 listings under this basis

Canada

Legal, prescribed off-label

Ketamine is a legal prescription medicine in Canada and clinics across the country offer it off-label for depression, often paired with psychotherapy.

Who can apply: Most clinics require a physician referral. All requirements

5 listings under this basis

Canada

Special Access Program

Health Canada's Special Access Program lets physicians request psilocybin or MDMA for individual patients with serious conditions, case by case. There are no licensed psilocybin centers yet.

Who can apply: Your physician applies to Health Canada's Special Access Program on your behalf. All requirements

Official source: Health Canada Special Access Program

United Kingdom

Legal, private clinics

Ketamine is a licensed medicine in the UK and a small number of private clinics and NHS services offer it off-label for depression. Psilocybin remains Schedule 1 outside research.

Who can apply: A psychiatric assessment at the clinic; some require a GP or psychiatrist referral letter. All requirements

5 listings under this basis

European Union

Legal, prescription only

Ketamine and esketamine are prescription medicines across the EU. Specialist clinics, mainly in Germany, the Netherlands, Spain, and Portugal, offer treatment for depression under medical supervision.

Who can apply: A specialist psychiatric assessment. All requirements

3 listings under this basis

Switzerland

Compassionate use permits

Switzerland grants case-by-case federal authorisations that let approved physicians treat individual patients with psilocybin, MDMA, or LSD. Access runs through a small number of authorised psychiatrists.

Who can apply: An authorised Swiss psychiatrist applies to the Federal Office of Public Health for an individual patient permit. All requirements

Official source: Swiss Federal Office of Public Health

Germany

Compassionate use program

Germany's medicines regulator (BfArM) approved a psilocybin compassionate use program for adults with treatment-resistant depression. It runs at two sites, in Mannheim and Berlin, for justified exceptional cases only, and capacity is expected to fall short of demand.

Who can apply: Adults with treatment-resistant depression where approved medicines have not helped and a clinical trial is not an option. All requirements

2 listings under this basisOfficial source: Central Institute of Mental Health, Mannheim

New Zealand

Individual prescriber approval

Psilocybin remains a Class A drug in New Zealand, but Medsafe can approve individual psychiatrists to prescribe it for treatment-resistant depression. Each approval is specific to the named prescriber.

Who can apply: A diagnosis of treatment-resistant depression, assessed by the approved psychiatrist. All requirements

1 listing under this basisOfficial source: New Zealand Ministry of Health

Netherlands

Truffles legal

Psilocybin truffles are legal to sell and consume in the Netherlands. Established retreat programs run multi-day guided sessions with preparation and integration support.

Who can apply: Adults only; retreats run their own health and medication questionnaires. All requirements

4 listings under this basis

Jamaica

Never scheduled

Psilocybin mushrooms were never made illegal in Jamaica. Retreat centers operate openly, and several run clinically informed programs with licensed therapists on staff.

Who can apply: Adults only; established retreats screen health and medications before booking. All requirements

2 listings under this basis

Peru

Legal, traditional medicine

Ayahuasca is legal in Peru and its traditional use is recognised as national cultural heritage. Established retreat centers around Iquitos and Cusco run multi-day programs; the serious ones screen health and medications before accepting guests.

Who can apply: Adults only; established centers require a health and medication questionnaire before accepting a booking. All requirements

6 listings under this basis

Costa Rica

Unscheduled

Ayahuasca is not a scheduled substance in Costa Rica, and several established centers operate openly with medical screening and on-site staff.

Who can apply: Adults only; health and medication screening before booking. All requirements

3 listings under this basis

Brazil

Legal in ceremonial context

Brazil legalised ayahuasca for religious and ceremonial use in 1987, the oldest legal framework in the world. Retreats operate within that ceremonial context.

Who can apply: Participation happens in a ceremonial context, which is what Brazilian law protects. All requirements

1 listing under this basis

Ecuador

Legal, traditional use

Traditional ayahuasca use is legal in Ecuador and centers operate openly, mostly in the Amazon and the southern highlands.

Who can apply: Adults only; health and medication screening at established centers. All requirements

1 listing under this basis

Colombia

Legal, traditional use

Yage (ayahuasca) ceremonies in the indigenous tradition are legal in Colombia. Only long-established centers with health screening are listed here.

Who can apply: Adults only; health and medication screening at established centers. All requirements

Mexico

Unscheduled

Ibogaine is not a scheduled substance in Mexico. Reputable providers run medically supervised programs with cardiac screening, typically for opioid dependence. Medical rigor varies widely, so vet providers carefully.

Who can apply: Cardiac screening with an EKG is non-negotiable; reputable clinics require it before arrival. All requirements

2 listings under this basis

What we exclude

No underground guides, no ceremony facilitators in countries where the substance is prohibited, no gray-market storefronts. MDMA-assisted therapy is not approved in the United States (the FDA declined the first application in 2024), so US MDMA treatment appears here only if that changes. If a listing seems to fall outside these rules, tell us and we will remove it.

General information, not legal or medical advice. 1937 listings are currently indexed. Verify current law and provider licensure before making decisions.